![AstraZeneca puts Covid-19 vaccine trial on hold over safety concern: Report | World News - Hindustan Times AstraZeneca puts Covid-19 vaccine trial on hold over safety concern: Report | World News - Hindustan Times](https://images.hindustantimes.com/rf/image_size_630x354/HT/p2/2020/09/09/Pictures/_c116b040-f22b-11ea-b62b-e96b83076abc.jpg)
AstraZeneca puts Covid-19 vaccine trial on hold over safety concern: Report | World News - Hindustan Times
![Nature, con AstraZeneca lieve aumento dei rischi di una rara malattia del sangue - Biotech - ANSA.it Nature, con AstraZeneca lieve aumento dei rischi di una rara malattia del sangue - Biotech - ANSA.it](https://www.ansa.it/webimages/ch_700/2020/1/24/d3b54c1b6219bcd7bee8ba036231cacf.jpg)
Nature, con AstraZeneca lieve aumento dei rischi di una rara malattia del sangue - Biotech - ANSA.it
![AstraZeneca has worked out 'winning formula' to boost COVID vaccine's efficacy, says firm's boss | Euronews AstraZeneca has worked out 'winning formula' to boost COVID vaccine's efficacy, says firm's boss | Euronews](https://static.euronews.com/articles/stories/05/23/33/64/1440x810_cmsv2_b0db36d3-73a2-5ebd-9e05-30e0e411561c-5233364.jpg)
AstraZeneca has worked out 'winning formula' to boost COVID vaccine's efficacy, says firm's boss | Euronews
![There's no proof the Oxford vaccine causes blood clots. So why are people worried? | David Spiegelhalter | The Guardian There's no proof the Oxford vaccine causes blood clots. So why are people worried? | David Spiegelhalter | The Guardian](https://i.guim.co.uk/img/media/422a0555aa096f00852278aa12a8ac2b17db85f2/0_550_8256_4954/master/8256.jpg?width=1200&height=1200&quality=85&auto=format&fit=crop&s=ca02434cda4f9d146bfbcce90608e416)
There's no proof the Oxford vaccine causes blood clots. So why are people worried? | David Spiegelhalter | The Guardian
![Vaxxers by Sarah Gilbert and Catherine Green; Until Proven Safe by Geoff Manaugh and Nicola Twilley – reviews | Science and nature books | The Guardian Vaxxers by Sarah Gilbert and Catherine Green; Until Proven Safe by Geoff Manaugh and Nicola Twilley – reviews | Science and nature books | The Guardian](https://i.guim.co.uk/img/media/b91a429dac0608ccf147181531e72d41bae600b9/106_82_3419_2217/master/3419.jpg?width=465&quality=45&auto=format&fit=max&dpr=2&s=fa6d1dbe66d6ccca2447fb2908ef0a6b)
Vaxxers by Sarah Gilbert and Catherine Green; Until Proven Safe by Geoff Manaugh and Nicola Twilley – reviews | Science and nature books | The Guardian
![AFPgraphics on Twitter: "The Oxford-AstraZeneca vaccine uses a viral-vector to deliver SARS-CoV-2 DNA and activate the immune system @AFP… " AFPgraphics on Twitter: "The Oxford-AstraZeneca vaccine uses a viral-vector to deliver SARS-CoV-2 DNA and activate the immune system @AFP… "](https://pbs.twimg.com/media/EnMAPcJXMAMoKWB.jpg)
AFPgraphics on Twitter: "The Oxford-AstraZeneca vaccine uses a viral-vector to deliver SARS-CoV-2 DNA and activate the immune system @AFP… "
![Vaccini, prima dose Astrazeneca e seconda Pfizer: il mix funziona. «Risposta immunitaria più potente», studio su Nature Vaccini, prima dose Astrazeneca e seconda Pfizer: il mix funziona. «Risposta immunitaria più potente», studio su Nature](https://www.ilmessaggero.it/photos/MED_HIGH/40/06/5974006_1717_prima_dose_astrazeneca_seconda_pfizer_mix_vaccini.jpg)
Vaccini, prima dose Astrazeneca e seconda Pfizer: il mix funziona. «Risposta immunitaria più potente», studio su Nature
![COVID: Are mix-and-match vaccines the way forward? | Science| In-depth reporting on science and technology | DW | 27.07.2021 COVID: Are mix-and-match vaccines the way forward? | Science| In-depth reporting on science and technology | DW | 27.07.2021](https://static.dw.com/image/57826635_303.jpg)
COVID: Are mix-and-match vaccines the way forward? | Science| In-depth reporting on science and technology | DW | 27.07.2021
![AstraZeneca: France says under 55s to receive different second dose of the COVID-19 vaccine | Euronews AstraZeneca: France says under 55s to receive different second dose of the COVID-19 vaccine | Euronews](https://static.euronews.com/articles/stories/05/53/13/84/320x180_cmsv2_92dde095-97d5-5961-a714-7623d563d219-5531384.jpg)